Publication | Closed Access

Darbepoetin alfa administered every 3 weeks alleviates anaemia in patients with solid tumours receiving chemotherapy; results of a double-blind, placebo-controlled, randomised study

Hematological MalignancyDarbepoetin AlfaOncologyMedicineHematologyClinical TrialsSolid TumoursPharmacotherapyCancer TreatmentPharmacologyCancer ResearchHealth Sciences